#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Precursor T-lymphoblastic lymphoma/leukaemia recurrent Cytomegalovirus infection Cognitive disorder Philadelphia positive chronic myeloid leukaemia Narcolepsy Ataxia telangiectasia Biliary neoplasm Epileptic encephalopathy Mantle cell lymphoma stage IV X-linked lymphoproliferative syndrome Neuroblastoma Arteriovenous malformation Langerhans cell sarcoma Primary mediastinal large B-cell lymphoma IgA nephropathy More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria Netherton’s syndrome – Basic Information Shprintzen-Goldberg syndrome – Treatment Leiomyosarcoma X-linked lymphoproliferative syndrome – Basic Information Ewing’s sarcoma recurrent – Trials in Disease Carcinoid syndrome – Diagnostics Mast cell activation syndrome – Basic Information Haemophilia A without inhibitors Cystic fibrosis lung – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivabradine LUTETIUM LU-177 Cl-Ad-Msc-002 Mesna Sirolimus Valganciclovir Ucp2 SODIUM SELENITE PENTAHYDRATE Latanoprost VANADIUM OXIDE SULFATE Epinephrine Hydrochloride Farletuzumab Ecteribulin ALXN1920 Mannitol Vinflunine Gemlapodect YOHIMBINE HYDROCHLORIDE Napabucasin Nicotinamide Bp Indacaterol Maleate More therapies…

    Learn about Your Condition

    Adrenogenital syndrome Bacteraemia Neurodermatitis Fibromyalgia Langerhans cell sarcoma Vertigo Weaning failure Pneumonia Short-bowel syndrome Haemolytic uraemic syndrome Hypoparathyroidism Thrombectomy Osteopenia Malabsorption Infertility male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on the Safety and Dosage of Ferumoxtran-10 for Examining Lymph Nodes in Rectal Cancer Patients Using NanoEcho Imaging Device

    Recruiting

    2 1 1
    Investigated Drugs:
    • FERUMOXTRAN-10
    Sweden

  • Study on the Effectiveness of Lidocaine Hydrochloride and Sodium Chloride for Treating Headaches in Patients with Spontaneous Brain Bleeding

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain

  • Study on IV NEPA (Fosnetupitant/Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients

    Recruiting

    4 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • 204-NETU
    • Fosaprepitant
    • Ondansetron
    Greece Poland Romania

  • Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Rituximab
    Poland

  • Study on Reducing Hospital Stay in Children with Complicated Appendicitis Using Amoxicillin and Clavulanic Acid

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    Spain

  • Study on the Effects of Alpha-1 Antitrypsin and Prednisolone in Patients with Severe Alcohol-Related Hepatitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    • Prednisolone
    Austria
Previous Page
1 2 3 4 5 6 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!